Skip to content
Biodatica
Start free

Investigator

Daniel J Greenberg

MEDIA REZ, LLC · funded by NCI

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.8M

Summed across those awards.

First award
Sep 10, 2020

Latest Sep 8, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    Patient-directed technology for non-pharmacologic management of cancer pain

    $404k

    Sep 8, 2025NCIMEDIA REZ, LLCNIH RePORTER · 11314954 (opens the source filing in a new tab)

  2. R44

    Intervention for Chronic Insufficient Sleep in Young Adult Cancer Patients and Survivors

    $735k

    Sep 10, 2020NCIMEDIA REZ, LLCNIH RePORTER · 11069198 (opens the source filing in a new tab)

  3. R44

    Intervention for Chronic Insufficient Sleep in Young Adult Cancer Patients and Survivors

    $696k

    Sep 10, 2020NCIMEDIA REZ, LLCNIH RePORTER · 11348878 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources